| Jun 14 |
Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored Presentations at the 84th Scientific Sessions of the American Diabetes Association
|
| Jun 14 |
Tango Therapeutics (TNGX) Moves 10.3% Higher: Will This Strength Last?
|
| Jun 11 |
Lexicon Pharmaceuticals (NASDAQ:LXRX) adds US$51m to market cap in the past 7 days, though investors from five years ago are still down 69%
|
| May 30 |
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
|
| May 29 |
Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024
|
| May 28 |
Lexicon Pharmaceuticals: Blue Sky Aplenty, Revenue Not So Much
|
